Skip to content
10-Q

Quarterly Report

TVARDI THERAPEUTICS, INC. TVRD

0001558370-25-011562

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 9.38M sh
Shares Diluted Q2 2025 · Jun 30, 2025 8.46M sh
Shares Diluted Q2 2025 · Jun 30, 2025 6.16M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 2.57M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 2.57M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$13.56M
Operating Cash Flow restated Q2 2025 · Jun 30, 2024 −$6.82M
Short Term Investments Q2 2025 · Jun 30, 2025 $20.35M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $20.65M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $31.61M
Stockholders Equity Q2 2025 · Jun 30, 2025 $32.93M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$100.63M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$91.13M
Stockholders Equity restated Q2 2025 · Jun 30, 2024 −$73.07M
Stockholders Equity restated Q2 2025 · Mar 31, 2024 −$66.17M
Stockholders Equity restated Q2 2025 · Dec 31, 2023 −$62.06M
Current Liabilities Q2 2025 · Jun 30, 2025 $10.68M
Current Liabilities Q2 2025 · Dec 31, 2024 $10.37M
Total Liabilities Q2 2025 · Jun 30, 2025 $10.82M
Total Liabilities Q2 2025 · Dec 31, 2024 $40.83M
Current Assets Q2 2025 · Jun 30, 2025 $43.13M
Current Assets Q2 2025 · Dec 31, 2024 $31.69M
Total Assets Q2 2025 · Jun 30, 2025 $43.75M
Total Assets Q2 2025 · Dec 31, 2024 $35.2M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.00
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.04
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$2.71
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$4.34
Eps Basic Q2 2025 · Jun 30, 2025 $0.51
Eps Basic Q2 2025 · Jun 30, 2025 −$1.00
Eps Basic restated Q2 2025 · Jun 30, 2024 −$2.71
Eps Basic restated Q2 2025 · Jun 30, 2024 −$4.34
Sga Expense Q2 2025 · Jun 30, 2025 $3.06M
Sga Expense Q2 2025 · Jun 30, 2025 $4.31M
Sga Expense restated Q2 2025 · Jun 30, 2024 $650K
Sga Expense restated Q2 2025 · Jun 30, 2024 $1.38M
Rd Expense Q2 2025 · Jun 30, 2025 $5.81M
Rd Expense Q2 2025 · Jun 30, 2025 $8.92M
Rd Expense restated Q2 2025 · Jun 30, 2024 $6.53M
Rd Expense restated Q2 2025 · Jun 30, 2024 $10.25M
Net Income Q2 2025 · Jun 30, 2025 $4.17M
Net Income Q2 2025 · Jun 30, 2025 −$5.41M
Net Income Q2 2025 · Mar 31, 2025 −$9.58M
Net Income restated Q2 2025 · Jun 30, 2024 −$6.98M
Net Income restated Q2 2025 · Jun 30, 2024 −$11.18M
Net Income restated Q2 2025 · Mar 31, 2024 −$4.2M
Operating Income Q2 2025 · Jun 30, 2025 −$8.87M
Operating Income Q2 2025 · Jun 30, 2025 −$13.22M
Operating Income restated Q2 2025 · Jun 30, 2024 −$7.18M
Operating Income restated Q2 2025 · Jun 30, 2024 −$11.63M